The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

32 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Synthesis, and Pharmacological Evaluation of 2-(2,5-Dimethyl-5,6,7,8-tetrahydroquinolin-8-yl)-N-aryl Propanamides as Novel Smoothened (Smo) Antagonists.EBI
University of Chinese Academy of Sciences
Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors via Tethering in Situ Click Chemistry.EBI
University of Chinese Academy of Sciences
Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human ClpP agonists.EBI
University of Chinese Academy of Sciences
Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile.EBI
University of Chinese Academy of Sciences
An overview of PROTACs targeting MDM2 as a novel approach for cancer therapy.EBI
University of Chinese Academy of Sciences
Discovery of Novel 2-Aminopyridine-Based and 2-Aminopyrimidine-Based Derivatives as Potent CDK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors and Hematological Malignancies.EBI
University of Chinese Academy of Sciences
Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy.EBI
University of Chinese Academy of Sciences
Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors.EBI
University of Chinese Academy of Sciences
Structure-based design of potent FABP4 inhibitors with high selectivity against FABP3.EBI
University of Chinese Academy of Sciences
Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CLpro Inhibitors as anti-SARS-CoV-2 Drug Candidate.EBI
University of Chinese Academy of Sciences
Discovery of a 1,6-naphthyridin-4-one-based AXL inhibitor with improved pharmacokinetics and enhanced in vivo antitumor efficacy.EBI
University of Chinese Academy of Sciences
Discovery of a Covalent Inhibitor That Overcame Resistance to Venetoclax in AML Cells Overexpressing BFL-1.EBI
University of Chinese Academy of Sciences
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer.EBI
University of Chinese Academy of Sciences
Structure-Activity Relationship Study of 1EBI
University of Chinese Academy of Sciences
Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties.EBI
University of Chinese Academy of Sciences
Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD.EBI
University of Chinese Academy of Sciences
Screening and optimization of phage display cyclic peptides against the WDR5 WBM site.EBI
University of Chinese Academy of Sciences
Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions.EBI
University of Chinese Academy of Sciences
Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold.EBI
University of Chinese Academy of Sciences
Design, synthesis and biological evaluation of tyrosinase-targeting PROTACs.EBI
University of Chinese Academy of Sciences
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation.EBI
University of Chinese Academy of Sciences
The components and activities analysis of a novel anticoagulant candidate dHG-5.EBI
University of Chinese Academy of Sciences
Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.EBI
University of Chinese Academy of Sciences
Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychotics.EBI
University of Chinese Academy of Sciences
Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors.EBI
University of Chinese Academy of Sciences
Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins.EBI
University of Chinese Academy of Sciences
Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors.EBI
University of Chinese Academy of Sciences
Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2YEBI
University of Chinese Academy of Sciences
Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists.EBI
University of Chinese Academy of Sciences
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.EBI
University of Chinese Academy of Sciences
Structural Modification of Natural Product Ganomycin I Leading to Discovery of a α-Glucosidase and HMG-CoA Reductase Dual Inhibitor Improving Obesity and Metabolic Dysfunction in Vivo.EBI
University of Chinese Academy of Sciences
Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer.EBI
University of Chinese Academy of Sciences